Summary: In an important decision, the Bombay High Court at Aurangabad has rejected a request by Hitesh P. Patel and others, who are partners of M/s Harsh Laboratories, holding them responsible for distributing Dicilin Capsules that did not meet quality standards. The case involves breaking the Drugs and Cosmetics Act, 1940.
The people who filed the request, Hitesh P. Patel, Ashokbhai C. Patel, Bharatbhai Vaghasia, and Kishorbhai Bhayani, are partners at M/s Harsh Laboratories in Ahmedabad. They were facing the State of Maharashtra, represented by Drugs Inspector M.K. Rajpal from the Food & Drug Administration in Dhule.
Petitioners' Defense: Hitesh P. Patel and his partners said they were only involved in selling, not making the drugs, so they shouldn't be blamed. They also said the complaint was made after the drug had expired.
Prosecution's Stand: The prosecution argued that Hitesh P. Patel and the other partners were supposed to ensure the product's quality and failed to challenge the lab report within the required 28 days.
Justice Khobragade decided that Hitesh P. Patel and his partners, being part of the company, were responsible for the company's actions. The court found enough evidence to move forward with the charges and rejected the petitioners' arguments.
The court decided that the partners of M/s Harsh Laboratories were responsible for the substandard drugs and could not avoid blame for not checking the quality of their products. This case shows how seriously the law treats the responsibility of ensuring drug safety to protect the public.
